Serum polybrominated diphenyl ether concentrations and thyroid function in young children

Melanie H Jacobson1, Dana B Barr2, Michele Marcus3

  • 1Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA 30322, USA.

Insights

Polybrominated diphenyl ethers (PBDEs) exposure in young children is linked to disruptions in thyroid hormone function, potentially indicating hypothyroidism. This study highlights the impact of PBDEs on thyroid-stimulating hormone (TSH) levels in U.S. children.

Area of Science:

  • Environmental Health
  • Endocrinology
  • Pediatric Toxicology

Background:

  • Thyroid hormones are critical for early neurodevelopment.
  • Polybrominated diphenyl ethers (PBDEs) are flame retardants with potential endocrine-disrupting properties.
  • Previous studies on PBDEs and thyroid function have yielded inconsistent results, with limited research in U.S. children.

Purpose of the Study:

  • To investigate the association between serum PBDE levels and thyroid hormone parameters in young children.
  • To assess PBDE exposure in children aged 1-5 years in the southeastern United States.
  • To determine if PBDE exposure is linked to subclinical thyroid function disruption.

Main Methods:

  • Serum levels of seven PBDE congeners and thyroid hormones were measured in 80 children (aged 1-5 years).
  • PBDEs were analyzed as individual congeners and as a sum (∑PBDE).
  • Multivariate linear regression models assessed associations between PBDE levels (quartiles and continuous) and thyroid markers, controlling for covariates.

Main Results:

  • PBDE congeners and ∑PBDE were positively associated with thyroid-stimulating hormone (TSH).
  • A log-unit increase in ∑PBDE was associated with a 22.1% increase in TSH.
  • Higher quartiles of ∑PBDE exposure correlated with increased TSH and a tendency towards lower total T4 and higher free T3.

Conclusions:

  • Childhood exposure to PBDEs is associated with subclinical disruption of thyroid hormone function.
  • Findings suggest PBDE exposure may contribute to a state of hypothyroidism in children.
  • This study provides evidence of PBDEs' impact on thyroid function in a U.S. pediatric population.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
315
Synthesis and Regulation of Thyroid Hormones01:20

Synthesis and Regulation of Thyroid Hormones

Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
8.8K
Functions of Thyroid Hormones01:18

Functions of Thyroid Hormones

The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
6.4K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
439